Irinotecan-induced dysarthria (multiple letters) [1]

Journal of the National Cancer Institute

Volumn 93, Issue 18, 2001, Pages 1419-1420

  Baz, David Vicente ^a   Bofill, Javier Salvador ^a   Moreno Nogueira, José Andrés ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMITRIPTYLINE; ATROPINE; CAMPTOTHECIN DERIVATIVE; DEXAMETHASONE; DIAZEPAM; FENTANYL; FLUOROURACIL; GADOLINIUM; IRINOTECAN; ONDANSETRON; OXALIPLATIN; TOPOTECAN;

ABDOMINAL PAIN; ADULT; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; APHASIA; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CHOLINERGIC SYSTEM; COLORECTAL CANCER; CONSTIPATION; CONVALESCENCE; DIARRHEA; DISEASE COURSE; DRUG DISTRIBUTION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG TOXICITY; DYSARTHRIA; FEMALE; FEVER; HUMAN; LETTER; MEDICAL LITERATURE; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; SIGMOID CARCINOMA; SKIN MANIFESTATION; SOLID TUMOR; STOMATITIS; THROMBOCYTOPENIA;

EID: 0035913646     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.18.1419     Document Type: Letter

References (0)